Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/26/26 16:34 | 12/15/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 7 | M.d | 703 | 10.04 | 0 | 70 | 49 | 214 | D | ||||||||||||||
1/26/26 16:34 | 12/15/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 7 | S.d | -703 | 10.04 | 0 | -70 | 214 | D | |||||||||||||||
1/26/26 16:33 | 12/22/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 6 | M.dm | 655 | 11.12 | 0 | 59 | 68 | 145 | D | ||||||||||||||
1/26/26 16:33 | 12/22/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 6 | S.dm | -655 | 11.12 | 0 | -59 | 145 | D | |||||||||||||||
12/29/25 17:10 | 11/24/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | 3 | M.dm | 322 | 7.70 | 0 | 42 | 310 | 55 | D | ||||||||||||||
12/29/25 17:10 | 11/24/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | 3 | S.dm | -322 | 7.70 | 0 | -42 | 55 | D | |||||||||||||||
12/18/25 18:02 | 12/16/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 3 | M.d | 1,093 | 9.78 | 0 | 112 | 49 | 339 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |